×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NUVB – nuvation bio inc. class a (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NUVB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/16
09:14 pm
nuvb
Nuvation Bio (NUVB): Reassessing Valuation After a 78% Monthly Surge in the Share Price [Yahoo! Finance]
Neutral
Report
Nuvation Bio (NUVB): Reassessing Valuation After a 78% Monthly Surge in the Share Price [Yahoo! Finance]
12/11
08:07 am
nuvb
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at HC Wainwright from $10.00 to $18.00. They now have a "buy" rating on the stock.
Medium
Report
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at HC Wainwright from $10.00 to $18.00. They now have a "buy" rating on the stock.
12/6
10:40 pm
nuvb
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
Low
Report
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
12/4
01:11 pm
nuvb
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result [Yahoo! Finance]
Low
Report
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result [Yahoo! Finance]
12/4
12:12 am
nuvb
Lenz Therapeutics: A Close Look [Seeking Alpha]
Low
Report
Lenz Therapeutics: A Close Look [Seeking Alpha]
12/3
11:58 am
nuvb
Nuvation Bio Inc. (NUVB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Medium
Report
Nuvation Bio Inc. (NUVB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
12/3
08:00 am
nuvb
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
High
Report
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
12/1
07:20 am
nuvb
Nuvation Bio (NYSE:NUVB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Neutral
Report
Nuvation Bio (NYSE:NUVB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Date
Time
Symbol
Company Name
Action
%Chg
11/3/2025
04:05 pm
nuvb
nuvation bio inc. class a
BEAT
Report
-6.6%
nuvation bio inc. class a
8/7/2025
07:30 am
nuvb
nuvation bio inc. class a
IN-LINE
Report
-3.7%
nuvation bio inc. class a
5/7/2025
04:05 pm
nuvb
nuvation bio inc. class a
IN-LINE
Report
2.9%
nuvation bio inc. class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
05:02 pm
nuvb
Form 4 Nuvation Bio Inc. For: Dec 01 Filed by: Liu Dongfang
Low
Report
Form 4 Nuvation Bio Inc. For: Dec 01 Filed by: Liu Dongfang
12/1
04:51 pm
nuvb
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Medium
Report
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
11/26
05:55 pm
nuvb
Form 4 Nuvation Bio Inc. For: Nov 25 Filed by: Liu Dongfang
Low
Report
Form 4 Nuvation Bio Inc. For: Nov 25 Filed by: Liu Dongfang
11/26
04:34 pm
nuvb
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Low
Report
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
11/26
08:34 am
nuvb
Form 8-K Nuvation Bio Inc. For: Nov 26
Low
Report
Form 8-K Nuvation Bio Inc. For: Nov 26
11/25
04:23 pm
nuvb
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
Low
Report
Form 144 Nuvation Bio Inc. Filed by: Liu Dongfang
11/24
04:10 pm
nuvb
Form 4 Nuvation Bio Inc. For: Nov 20 Filed by: Hattersley Gary
Medium
Report
Form 4 Nuvation Bio Inc. For: Nov 20 Filed by: Hattersley Gary
11/24
04:09 pm
nuvb
Form 4 Nuvation Bio Inc. For: Nov 20 Filed by: Liu Dongfang
Medium
Report
Form 4 Nuvation Bio Inc. For: Nov 20 Filed by: Liu Dongfang
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: